Literature DB >> 10361226

Complement activation and expression of membrane regulators in the middle ear mucosa in otitis media with effusion.

M Närkiö-Mäkelä1, J Jero, S Meri.   

Abstract

The aetiopathogenesis of chronic otitis media with effusion (OME) in children is not yet fully understood. OME is characterized by metaplasia of the epithelium and accumulation of sticky, glue-like effusion in the middle ear containing different mediators of inflammation, including activation fragments of the complement system. Here we examined whether the fluid phase complement activation is reflected in the middle ear mucosa and how the mucosa is protected against the cytolytic activity of complement. Mucosal biopsies from 18 middle ears of children with a history of chronic OME were taken. The biopsies were analysed by immunofluorescence microscopy after staining for complement fragments iC3b/C3c, C3d and C9, and regulators membrane cofactor protein (MCP; CD46), decay-accelerating factor (DAF; CD55) and protectin (CD59). There was a strong staining for iC3b/C3c, and a weaker one for C3d and C9 on the surface of the middle ear epithelial cells of OME patients but not in controls without OME. MCP was expressed on the hyperplastic three to four outer cell layers of the epithelium, while CD59 was expressed throughout the middle ear mucosa. The results suggest a strong ongoing complement activation and consequent inflammation in the middle ear cavity. Unrestricted complement damage of the epithelial lining is prevented by the strong expression of MCP and CD59.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10361226      PMCID: PMC1905301          DOI: 10.1046/j.1365-2249.1999.00916.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Recent advances in otitis media. Definition and classification.

Authors:  J O Klein; M Tos; B Hussl; R F Naunton; M Ohyama; P B van Cauwenberge
Journal:  Ann Otol Rhinol Laryngol Suppl       Date:  1989-04

2.  Improved mountant for immunofluorescence preparations.

Authors:  G V Heimer; C E Taylor
Journal:  J Clin Pathol       Date:  1974-03       Impact factor: 3.411

3.  Bacteria associated with acute otitis media have high Clq binding capacity.

Authors:  K Prellner
Journal:  Acta Pathol Microbiol Scand C       Date:  1980-08

4.  Characteristics of secretory immune system in human middle ear: implications in otitis media.

Authors:  P L Ogra; J M Bernstein; A M Yurchak; P R Coppola; T B Tomasi
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

5.  Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.

Authors:  S Meri; B P Morgan; A Davies; R H Daniels; M G Olavesen; H Waldmann; P J Lachmann
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

6.  Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.

Authors:  S A Rollins; J Zhao; H Ninomiya; P J Sims
Journal:  J Immunol       Date:  1991-04-01       Impact factor: 5.422

7.  Complement in chronic secretory otitis media. C3 breakdown and C3 splitting activity.

Authors:  S Meri; T Lehtinen; T Palva
Journal:  Arch Otolaryngol       Date:  1984-12

8.  Chemotactic activity in middle ear effusions.

Authors:  J M Bernstein; B H Park
Journal:  Otolaryngol Head Neck Surg       Date:  1981 Nov-Dec       Impact factor: 3.497

9.  Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis.

Authors:  H F Weisman; T Bartow; M K Leppo; H C Marsh; G R Carson; M F Concino; M P Boyle; K H Roux; M L Weisfeldt; D T Fearon
Journal:  Science       Date:  1990-07-13       Impact factor: 47.728

10.  Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids.

Authors:  M E Medof; E I Walter; J L Rutgers; D M Knowles; V Nussenzweig
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

View more
  9 in total

1.  Cytolytic complement activity in otitis media with effusion.

Authors:  M Närkiö-Mäkelä; S Meri
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

2.  Expression of complement regulating factors in gastric cancer cells.

Authors:  T Inoue; M Yamakawa; T Takahashi
Journal:  Mol Pathol       Date:  2002-06

3.  Essential role of factor B of the alternative complement pathway in complement activation and opsonophagocytosis during acute pneumococcal otitis media in mice.

Authors:  Qian Li; Yong Xing Li; Gregory L Stahl; Joshua M Thurman; Yujuan He; Hua Hua Tong
Journal:  Infect Immun       Date:  2011-04-18       Impact factor: 3.441

4.  Dysregulation of immune response in otitis media.

Authors:  Michael W Mather; Steven Powell; Benjamin Talks; Chris Ward; Colin D Bingle; Muzlifah Haniffa; Jason Powell
Journal:  Expert Rev Mol Med       Date:  2021-08-18       Impact factor: 7.615

5.  Binding of complement regulators to invasive nontypeable Haemophilus influenzae isolates is not increased compared to nasopharyngeal isolates, but serum resistance is linked to disease severity.

Authors:  Teresia Hallström; Fredrik Resman; Mikael Ristovski; Kristian Riesbeck
Journal:  J Clin Microbiol       Date:  2010-01-20       Impact factor: 5.948

6.  Complement activation in pediatric patients with recurrent acute otitis media.

Authors:  Yujuan He; Melissa A Scholes; Gregory J Wiet; Qian Li; Caitlin Clancy; Hua Hua Tong
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2013-03-26       Impact factor: 1.675

7.  Expression of measles virus receptors in otosclerotic, non-otosclerotic and in normal stapes footplates.

Authors:  Tamás Karosi; István Jókay; József Kónya; Mihály Petkó; László Z Szabó; István Sziklai
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-02-09       Impact factor: 3.236

8.  Synergy of protease-binding sites within the ecotin homodimer is crucial for inhibition of MASP enzymes and for blocking lectin pathway activation.

Authors:  Zoltán Attila Nagy; Dávid Héja; Dániel Bencze; Bence Kiss; Eszter Boros; Dávid Szakács; Krisztián Fodor; Matthias Wilmanns; Andrea Kocsis; József Dobó; Péter Gál; Veronika Harmat; Gábor Pál
Journal:  J Biol Chem       Date:  2022-04-25       Impact factor: 5.486

9.  The role of inflammatory mediators in the pathogenesis of otitis media and sequelae.

Authors:  Steven K Juhn; Min-Kyo Jung; Mark D Hoffman; Brian R Drew; Diego A Preciado; Nicholas J Sausen; Timothy T K Jung; Bo Hyung Kim; Sang-Yoo Park; Jizhen Lin; Frank G Ondrey; David R Mains; Tina Huang
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-09-30       Impact factor: 3.372

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.